About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
EGRX - Eagle Pharmaceutical...| Previous Close | $41.61 | Open | $41.67 |
| Volume | 155.9K | Market Cap | 700.21M |
| Yield | Last Dividend |
| Eagle Pharmaceuticals??? Japanese Licens... | 09/23/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (???Eagle??? or the ???Company???) (NASDAQ: EGRX) today announced that its marketin... | |
| Eagle Pharmaceuticals to Present at Upco... | 09/08/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (???Eagle??? or the ???Company???) (NASDAQ: EGRX) today announced that Scott Tarrif... | |
| Eagle Pharmaceuticals Announces Publicat... | 08/19/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle??? or the ???Company???) today announced that preclinical ... | |
| The Week Ahead In Biotech: Spotlight On ... | 08/16/20 |
| Biotech stocks came under pressure in the week ended Aug. 14 amid mixed earnings news flow from the sector. FDA decisions scheduled for the week also ... | |
| Eagle Pharmaceuticals Reports Second Qua... | 08/10/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle??? or the ???Company???) today announced financial results... | |
| Earnings Scheduled For August 10, 2020 | 08/10/20 |
| Companies Reporting Before The Bell ??? Acacia Research Inc. (NASDAQ: ACTG ) is expected to report quarterly loss at $0.02 per share on revenue of $20... | |
| The Week Ahead In Biotech: Bausch Health... | 08/09/20 |
| Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and c... | |
| Eagle Pharmaceuticals to Discuss Second ... | 08/03/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (???Eagle??? or the ???Company???) (Nasdaq: EGRX) today announced that the Company ... | |
| The Week Ahead In Biotech: Novavax Coron... | 08/02/20 |
| Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flo... | |
| Attention Biotech Investors: Mark Your C... | 07/31/20 |
| July turned out to be a mixed month for FDA approvals. Endo International PLC's (NASDAQ: ENDP ) cellulite treatment, Osmotica Pharmaceuticals PLC's (N... | |
| The Week Ahead In Biotech: Endo, Eagle P... | 07/06/20 |
| Biotech stocks rebounded in the holiday-shortened week ending July 2 as investors reacted to pending clinical trial readouts and the news flow surroun... | |
| Eagle Pharmaceuticals to Present at June... | 05/26/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle??? or the ???Company???) today announced that Scott Tarrif... | |
| Eagle Pharmaceuticals Announces Change t... | 05/22/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle???) announced today that, due to public health and safety ... | |
| Eagle Pharmaceuticals to Present at the ... | 05/12/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle??? or the ???Company???) today announced that Scott Tarrif... | |
| Eagle Pharmaceuticals (EGRX) Q1 Earnings... | 05/11/20 |
| Eagle Pharmaceuticals (EGRX) delivered earnings and revenue surprises of 78.72% and -3.63%, respectively, for the quarter ended March 2020. Do the num... | |
| Fed Circuit okays generic version of Eag... | 05/08/20 |
| Generic drug company Slayback Pharma LLC on Friday won an appeals court decision that clears the way for it to launch a generic version of the Eagle P... | |
| Why Eagle Pharmaceuticals (EGRX) Might S... | 05/08/20 |
| Eagle Pharmaceuticals (EGRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings seaso... | |
| Eagle Pharmaceuticals Advances Novel and... | 05/04/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (???Eagle??? or the ???Company???) (NASDAQ: EGRX) today provided an update on its p... | |
| Eagle Pharmaceuticals to Discuss First Q... | 04/29/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (???Eagle??? or the ???Company???) (Nasdaq: EGRX) today announced that the Company ... | |
| Eagle Pharmaceuticals Announces Laborato... | 04/16/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle???), a New Jersey-based pharmaceutical company, today anno... | |
| Eagle Pharmaceuticals??? Japanese Licens... | 03/30/20 |
| Eagle Pharmaceuticals, Inc. (???Eagle??? or the ???Company???) (NASDAQ: EGRX) today announced that its marketing partner SymBio Pharmaceuticals Limite... | |
| The Daily Biotech Pulse: Roche Obtains F... | 03/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) ... | |
| The Daily Biotech Pulse: Mesoblast To Te... | 03/10/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) A... | |
| The Daily Biotech Pulse: Breakthrough De... | 03/06/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5... | |
| The Daily Biotech Pulse: GenMark Diagnos... | 03/03/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 2) ... | |
| Eagle Pharmaceuticals (NASDAQ: EGRX): Q4... | 03/02/20 |
| ??? Eagle Pharmaceuticals Inc. (NASDAQ: EGRX) reported its fourth-quarter 2019 adjusted earnings of $0.48 per share versus $0.46 per share expected. ?... | |
| Eagle Pharmaceuticals Reports Fourth Qua... | 03/02/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle??? or the ???Company???) today announced financial results... | |
| Eagle Pharmaceuticals to Discuss Fourth ... | 02/19/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. ("Eagle" or the ???Company???) (Nasdaq: EGRX) today announced that the Company will... | |
| Eagle Pharma nabs final FDA nod for Pemf... | 02/10/20 |
| The FDA has granted final approval to Eagle Pharmaceuticals' (EGRX -0.4%) Pemfexy (pemetrexed for injection), its branded alternative to Eli Lilly's (... | |
| Eagle Pharmaceuticals Receives Final FDA... | 02/10/20 |
| WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (???Eagle??? or the ???Company???) today announced that it has recei... | |
| Date | 2020-08-10 (BMO) | Est. (EPS/Rev.) | $0.26/ 42.28M |
| Actual (EPS/Rev.) | $0.57/ $41.94 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Burdeshaw Investing | Matthew Burdeshaw | 55.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
